Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-12-08

FDA Approved: ONDANSETRON — Supplemental Application (NorthStar Rx LLC)

View source ↗

Summary

The FDA approved a supplemental application for ondansetron hydrochloride (ANDA) filed by NorthStar Rx LLC.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Ondansetron hydrochloride (ondansetron hydrochloride)

Snippet

SUPPL AP for ONDANSETRON (ONDANSETRON HYDROCHLORIDE)